ArticleJournal of cardiothoracic surgery2024

Study on the efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy regimen for III-IVA esophageal squamous cell carcinoma post-surgery.

Chunyang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.